Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.
The purpose of this study is to determine if an investigational treatment can address the underlying cause of Graves' disease, and potentially normalize thyroid hormone levels.
We are creating a new way to understand online sexual harassment. As technology changes, people find new ways to harm others online. Current tools don't catch all these new types of harassment.
Help us improve resources for patients with rheumatic conditions! This is a brief, anonymous survey aimed to gather information about what additional resources you'd like to learn about from your rheumatology care team. Learning about your interest and priorities will inform future development of programs, resources, and tools to promote health.
This study is exploring whether the new drug combo of TNG462 + RMC‑6236/9805 can be safely given to patients with tough pancreatic or lung cancers that have specific genetic markers, and if it shows promising early signs of fighting the cancer.
Would you like to learn more about your body composition and resting metabolic rate? If you identify as Asian and are between 18-35 years old, you may be eligible to participate in a research study evaluating body composition and metabolic health in multiple Asian ethnicities.
This project aims to test the cognitive mechanisms involved in language production by healthy adults.
Do you have a cough that hasn't gone away for more than 8 weeks? Does your cough bother you or make it hard to do normal activities? If your cough continues and you feel it is not well managed, you may be able to participate in a research study to find out how chronic cough is treated and how it affects daily life and other health conditions. Compensation provided.
This study is being done to see if an investigational medication works better than a placebo (dummy medicine) for weight loss.
Do you have plaque type psoriasis? You may be able to participate in a research study to find out if an investigational medication (zasocitinib) works better than an already FDA approved medication for psoriasis (deucravacitinib).